Our data revealing statistically higher levels in ISS-III patients compared to ISS-I patients, as well in the G2 vs. G1 group, confirm the results of several studies that OPN levels reflect the progression of MM and MBD well [42,61,64]. This evidence concerns the gene SPP1 and Miyoshi myopathy.